Brady Johnson's most recent trade in Cidara Therapeutics Inc was a trade of 20,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 31, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | Brady Johnson | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Brady Johnson | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 10,000 | 59,366 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Brady Johnson | Vice President, Finance | Sale of securities on an exchange or to another person at price $ 0.81 per share. | 21 Mar 2022 | 654 | 49,366 (0%) | 0% | 0.8 | 530 | Common Stock |
| Cidara Therapeutics Inc | Brady Johnson | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 20,750 | 47,119 (0%) | 0% | 0 | Common Stock |